NDT Plus Advance Access published online on April 28, 2009
NDT Plus, doi:10.1093/ndtplus/sfp044
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients
1 Salford Royal NHS Foundation Trust, Manchester, UK
2 Department of Nephrology B, Herlev Hospital, University of Copenhagen, Denmark
Correspondence: Helen Eddington; E-mail: heddington{at}doctors.org.uk
| Abstract |
|---|
Management of chronic kidney disease–mineral bone disorder can be difficult in renal patients. This review aims to explain why the control of disturbed calcium, phosphate, parathyroid hormone and vitamin D metabolism is important in dialysis patients. The methods available to regulate these parameters include diet, phosphate binders, dialysate calcium, native vitamin D, active vitamin D derivatives and calcimimetics. An overview of current treatment guidelines will be discussed.
Key Words: calcium phosphate PTH uraemia vitamin D
Received for publication February 19, 2009. Accepted for publication April 3, 2009.